前瞻性评估浊度法β-D-葡聚糖试验与两种侧向层析法在侵袭性曲霉病血清诊断中的价值
该前瞻性研究纳入239例血液病患者血清样本,评估IMMY侧向层析法(LFA)、OLM侧向层析装置(LFD)和Wako浊度法β-D-葡聚糖试验对侵袭性曲霉病(IA)的诊断性能。结果显示LFA的阴性预测值和敏感性最高(0.90和0.49),半乳甘露聚糖检测的阳性预测值和特异性最高(0.93和0.99);LFA与β-D-葡聚糖联合可提高阴性预测值。
要点
- LFA诊断IA敏感性0.49、NPV 0.90,可作为半乳甘露聚糖的快速替代。
- 半乳甘露聚糖特异性0.99、PPV 0.93最高,但LFA敏感性不显著低于它。
- LFA联合Wako β-D-葡聚糖检测可进一步提升诊断性能。
核心结论
- LFA是诊断IA快速有效的半乳甘露聚糖替代方法,尤其适合样本量少的中心。
- 联合Wako β-D-葡聚糖检测可进一步改善诊断性能。
研究设计与样本
- 前瞻性收集239例血液病患者血清样本,采用2019 EORTC/MSG定义评估三种检测。
主要发现
- 共5例确诊IA、36例临床诊断IA、188例对照。
- LFA的NPV和敏感性最高(0.90和0.49),半乳甘露聚糖的PPV和特异性最高(0.93和0.99)。
- LFA与半乳甘露聚糖敏感性无显著差异;LFD敏感性显著低于LFA。
- 去除血清半乳甘露聚糖以控制纳入偏倚后,LFA敏感性优于半乳甘露聚糖检测(0.41 vs 0.31,P = .046)。
- LFA阴性且β-D-葡聚糖阴性时NPV最高。
关键数值与推荐
- LFA敏感性0.49、NPV 0.90;半乳甘露聚糖特异性0.99、PPV 0.93。
- 去除半乳甘露聚糖定义后LFA敏感性0.41 vs 半乳甘露聚糖0.31,P = .046。
临床怎么用
- 对血液病等高危患者,可用LFA快速筛查IA,阴性时联合β-D-葡聚糖检测提高排除信心。
- 样本量少的中心可优先选用LFA替代半乳甘露聚糖检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Invasive aspergillosis (IA) remains a potentially lethal disease and requires timely diagnosis and initiation of antifungal therapy. Recently, the IMMY lateral flow assay (LFA), the OLM Diagnostics lateral flow device (LFD), and the Wako turbidimetric β-d-glucan assay have been approved for use as a diagnostic aid. However, their performance in diagnosing IA on serum samples from at-risk patients and the added value to the existing detection of serum galactomannan remain to be investigated. METHODS: We prospectively collected serum samples from 239 hematology patients and evaluated the diagnostic performance of these 3 assays while using the 2019 EORTC/MSG definitions (study number S59863/S61797, NCT03004092). RESULTS: We identified 5 cases of proven IA, 36 cases of probable IA, and 188 controls. The LFA had the highest negative predictive value (NPV) and sensitivity (0.90 and 0.49, respectively) while galactomannan detection had the highest positive predictive value and specificity (0.93 and 0.99, respectively). Sensitivity was not significantly different between both tests. When used in combination, the highest NPV was seen in patients with a negative LFA and a negative β-d-glucan test. The sensitivity of the LFD was significantly lower than the LFA. After omitting serum galactomannan from the definitions to control for incorporation bias, the sensitivity of the LFA outperformed galactomannan detection (0.41 vs 0.31, P = .046). CONCLUSIONS: The LFA is a fast and effective alternative to serum galactomannan detection for the diagnosis of IA and is especially useful for centers with low sample throughputs. The addition of the Wako β-D-glucan assay further improves the diagnostic performance.
引用
- Mercier T, Guldentops E, Lagrou K, et al. Prospective Evaluation of the Turbidimetric β-D-Glucan Assay and 2 Lateral Flow Assays on Serum in Invasive Aspergillosis. Clin Infect Dis. 2021. PMID: 32188971. doi:10.1093/cid/ciaa295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。